Golden
Vivo Capital

Vivo Capital

Vivo Capital is a Palo Alto, California-based venture capital company.

Vivo Capital is a healthcare focused investment firm formed in 1996 with over $1 billion under management. Vivo Capital makes investments from its $375M seventh fund into private and public healthcare companies in the U.S. and greater China. Vivo Capital has offices in Palo Alto, California, Shanghai, Chengdu, and Beijing, China.



 Vivo's portfolio includes more than 80 private and public biotechnology companies in the areas of biopharmaceuticals, specialty pharmaceuticals, and medical devices. Vivo Capital has made 105 investments and has raised a total of $5.4B across 8 funds.

Funds

Vivo making investments from its $1.4B Vivo Capital Fund IX into private healthcare companies, from its $635M Vivo Opportunity Fund into public healthcare companies, and from its $100M Vivo Innovation (PANDA) Fund into early-stage healthcare companies.

Vivo Capital Fund IX

Vivo Capital Fund IX and its predecessor funds are growth capital and private equity-focused investment vehicles investing in the healthcare industry. Vivo invests in companies that develop and commercialize therapeutics, including pharmaceuticals, biotechnology and medical devices. Their growth capital investments help portfolio companies accelerate revenue ramp or fund product development to drive value creation. Their private equity investments focus primarily on buyouts, privatizations, and spin-off opportunities. They invest in structures ranging from minority equity investments to control transactions with a primary focus on the U.S. and Greater China.

Vivo Opportunity Fund

Vivo Opportunity Fund primarily invests in the global public equities of small and mid-cap biotechnology, pharmaceutical, healthcare and life science companies. The fund is long only and often invests directly into companies through various financing structures, including follow-ons, secondaries, PIPEs, ATM purchases, and IPOs.

Vivo Innovation Fund

Vivo Innovation Fund (i.e., Vivo PANDA Fund) focuses on investing in venture stage companies with the potential to develop healthcare technologies or products. The fund typically invests in early stage (i.e. Series A) financing rounds.

Timeline

Funded Companies

17 Results
Company
Company
Description
Description
Website
Website
Industry
Industry
Location
Location

Precision BioSciences is a biotechnology developing a gene editing platform for the creation of cell therapies, gene therapies, and agricultural products.

Poseida Therapeutics develops targeted cell therapy.

Impel NeuroPharma is a Seattle-based healthcare company.

Bolt Biotherapeutics is developing its novel BoltbodyTM platform, a cancer immunotherapy that consists of Immune-Stimulating Antibody Conjugates (ISAC).

Maculogix is a Middletown, Pennsylvania-based healthcare company.

Homology Medicines is a Bedford, Massachusetts-based company.

Platelet BioGenesis is a Cambridge, Massachusetts-based company.

Swift Health Systems dba INBRACE is a medical device company.

REVOLUTION Medicines is a Redwood City, California-based company.

Arcutis Biotherapeutics, Inc. is a Westlake Village, California-based company.

IGM Biosciences is a Mountain View, California-based company.

Menlo Therapeutics is a Redwood City, California-based company.

Cerebral Therapeutics is an Aurora, Colorado-based company.

Harmony Biosciences is a Plymouth Meeting, Pennsylvania-based company.

MetacrineSciences is a San Diego-based company.

Associated investment funds

4 Results
Investment Fund
Investment Fund
Total offering (USD)
Total offering (USD)
Total sold (USD)
Total sold (USD)
Location
Location
Date signed
Date signed
100,306,122
100,306,122
June 1, 2016
427,650,000
427,650,000
December 17, 2014

People

Name
Role
LinkedIn







Further reading

Title
Author
Link
Type
Date









Documentaries, videos and podcasts

Title
Date
Link





Companies

Company
CEO
Location
Products/Services









References